Moreover, delivery of the LAV-BPIFB4 gene exerted therapeutic action in murine models of atherosclerosis, limb ischemia, diabetic cardiomyopathy, and aging. This evidence concerns the gene BPIFB4 and diabetic cardiomyopathy.